Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. Colony-stimulating factors such as G-CSF may increase the number
of immune cells found in the bone marrow or peripheral blood and may help a person's immune
system recover after chemotherapy and radiation therapy. Combining more than one drug and
giving drugs in different ways may kill more cancer cells.
PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy
with or without G-CSF in treating older patients with acute myeloid leukemia.
Phase:
Phase 3
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC